I am Dr. Berkay Kılıç, a specialist in surgical oncology at the Istanbul University Oncology Institute, where I have been practicing since 2015. My primary focus is the surgical treatment of breast cancer, with expertise in oncoplastic surgery, breast-conserving surgery, breast reconstruction, and single-stage direct-to-implant reconstruction techniques.
My research primarily investigates oncologic safety, recurrence rates, and surgical outcomes in breast cancer patients. I have conducted studies on the efficacy of single-stage direct-to-implant breast reconstruction, artificial intelligence-assisted biopsy techniques, and the assessment of residual disease following neoadjuvant systemic therapy.
I have authored and co-authored multiple peer-reviewed publications in national and international journals and have presented my research at academic conferences. My ongoing work aims to contribute to advancements in breast cancer surgery by refining surgical techniques and optimizing patient outcomes.
I am Dr. Berkay Kılıç, a specialist in surgical oncology at the Istanbul University Oncology Institute, where I have been practicing since 2015. My primary focus is the surgical treatment of breast cancer, with expertise in oncoplastic surgery, breast-conserving surgery, breast reconstruction, and single-stage direct-to-implant reconstruction techniques.
My research primarily investigates oncologic safety, recurrence rates, and surgical outcomes in breast cancer patients. I have conducted studies on the efficacy of single-stage direct-to-implant breast reconstruction, artificial intelligence-assisted biopsy techniques, and the assessment of residual disease following neoadjuvant systemic therapy.
I have authored and co-authored multiple peer-reviewed publications in national and international journals and have presented my research at academic conferences. My ongoing work aims to contribute to advancements in breast cancer surgery by refining surgical techniques and optimizing patient outcomes.